For: | Yao HW, Li J, Chen JQ, Xu SY. Leflunomide attenuates hepatocyte injury by inhibiting Kupffer cells. World J Gastroenterol 2004; 10(11): 1608-1611 [PMID: 15162534 DOI: 10.3748/wjg.v10.i11.1608] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v10/i11/1608.htm |
Number | Citing Articles |
1 |
Menna Nafea, Mona Elharoun, Mohammad Mohmoud Abd-Alhaseeb, Maged Wasfy Helmy. Leflunomide abrogates neuroinflammatory changes in a rat model of Alzheimer’s disease: the role of TNF-α/NF-κB/IL-1β axis inhibition. Naunyn-Schmiedeberg's Archives of Pharmacology 2023; 396(3): 485 doi: 10.1007/s00210-022-02322-3
|
2 |
Titia E. Vrenken, Manon Buist-Homan, Allard Jan Kalsbeek, Klaas Nico Faber, Han Moshage. The active metabolite of leflunomide, A77 1726, protects rat hepatocytes against bile acid-induced apoptosis. Journal of Hepatology 2008; 49(5): 799 doi: 10.1016/j.jhep.2008.07.019
|
3 |
|
4 |
Tao-tao Ma, Xiao-feng Li, Wan-xia Li, Yang Yang, Cheng Huang, Xiao-ming Meng, Lei Zhang, Jun Li. Geniposide alleviates inflammation by suppressing MeCP2 in mice with carbon tetrachloride-induced acute liver injury and LPS-treated THP-1 cells. International Immunopharmacology 2015; 29(2): 739 doi: 10.1016/j.intimp.2015.08.045
|